Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.69USD
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
$2.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
367,091
52-wk High
$5.05
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.26 -0.174
FY 2018 Dec '18 0.61 -0.177
Sep '18 0.38 -0.208
Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 8 1.99 3.70 0.80 --
Quarter Ending Dec-19 8 3.09 4.30 1.13 --
Year Ending Dec-19 8 6.48 12.00 2.73 22.35
Year Ending Dec-20 8 30.22 47.20 19.43 59.22
Earnings (per share)
Quarter Ending Sep-19 7 -0.23 -0.21 -0.26 --
Quarter Ending Dec-19 7 -0.23 -0.20 -0.25 --
Year Ending Dec-19 7 -0.85 -0.79 -0.93 -0.68
Year Ending Dec-20 7 -0.66 -0.47 -0.84 -0.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 97.98 34.52
P/E High - Last 5 Yrs. -- 169.30 54.21
P/E Low - Last 5 Yrs. -- 53.46 28.29
Beta 2.14 1.29 0.99
Price to Sales (TTM) 102.40 42.23 7.97
Price to Book (MRQ) -- 12.30 4.45
Price to Tangible Book (MRQ) -- 17.07 5.18
Price to Cash Flow (TTM) -- 64.34 24.33
% Owned Institutions 16.16 3.23 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.63
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.85 6.83
Payout Ratio(TTM) -- 2.43 47.44

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -22.74 67.62 14.69
Sales (TTM) vs TTM 1 Yr. Ago -60.36 49.06 8.20
Sales - 5 Yr. Growth Rate -40.77 33.40 9.46
EPS (MRQ) vs Qtr. 1 Yr. Ago 23.75 -6.26 18.14
EPS (TTM) vs TTM 1 Yr. Ago -141.29 -- --
EPS - 5 Yr. Growth Rate -- 22.67 7.10
Capital Spending - 5 Yr. Growth Rate -24.26 26.51 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.91 2.79 2.54
Current Ratio (MRQ) 5.03 3.88 3.54
LT Debt to Equity (MRQ) -- 7.90 12.58
Total Debt to Equity (MRQ) -- 20.96 17.60
Interest Coverage (TTM) -14.58 31.43 14.89

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -97.40 23.23 50.19
Gross Margin - 5 Yr. Avg. -- 59.05 51.31
EBITD Margin (TTM) -1,882.39 -- --
EBITD - 5 Yr. Avg -300.08 -11.70 16.45
Operating Margin (TTM) -1,918.77 -122.20 -6.60
Operating Margin - 5 Yr. Avg. -315.43 -27.79 11.94
Pre-Tax Margin (TTM) -2,374.77 -123.99 -6.95
Pre-Tax Margin - 5 Yr. Avg. -383.85 -32.85 15.91
Net Profit Margin (TTM) -2,374.87 -129.71 -10.73
Net Profit Margin - 5 Yr. Avg. -318.30 -37.76 11.28
Effective Tax Rate (TTM) -- 17.16 20.55
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.50

Efficiency

  Company industry sector
Revenue/Employee (TTM) 33,984 10,321,994 879,617,670
Net Income/Employee (TTM) -807,066 2,332,961 102,957,990
Receivable Turnover (TTM) 4.18 12.39 5.90
Inventory Turnover (TTM) 2.67 2.40 3.64
Asset Turnover (TTM) 0.02 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.93 6.42 10.25
Return on Assets - 5 Yr. Avg. -32.76 6.15 11.20
Return on Investment (TTM) -66.95 7.77 12.69
Return on Investment - 5 Yr. Avg. -37.33 8.01 14.18
Return on Equity (TTM) -- 8.27 17.17
Return on Equity - 5 Yr. Avg. -215.93 8.94 15.55
  1 Year 3 Year 5 Year
Sales % -73.10 -51.85 -40.77
EPS (TTM) % -117.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 15.74 14.73 88 1
13 Week -19.53 -21.46 36 5
26 Week 8.37 -2.77 64 23
52 Week -7.80 -13.13 66 6
YTD 17.75 -0.83 61 7
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.16%
# of Holders: 87
Total Shares Held: 12,748,822
3 Mo. Net Change: -39,947
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 4
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.